IDOX

Frankel UK Bidco has received acceptances for around 90.2% of Idox shares and is now pursuing a compulsory acquisition under UK law to buy the remaining shares on the same terms. Idox has applied to cancel its admission to AIM; the delisting is expected to take effect on 29 May, after which Frankel intends to convert Idox into a private company. Remaining shareholders will receive notices about the compulsory acquisition, and the liquidity of their shares will be significantly reduced after the delisting; the offer can still be accepted until Wednesday at 1:00 p.m. London time. » Más en de.investing.com

The British takeover panel, at the joint request of Frankel and Idox, has suspended the previously set offer timetable for the takeover of Idox. The decision was announced on Friday and delays the further progress of the takeover process. » Más en de.investing.com

Long Path Partners has received valid acceptances for around 19.12% of Idox shares under the ongoing cash takeover offer; the offer by Frankel UK Bidco values each share at 71.5 pence. Together with shares already held, the bidder can count about 25.34% of the capital; the target is more than 50% of the voting rights, and the acceptance period runs until 16 March 2026. If it acquires ≥75% Frankel plans to delist from AIM; at ≥90% the company intends a compulsory acquisition of the remaining shares. » Más en de.investing.com